MedPath

Immunity and Infections in the Psychiatric Population

Not Applicable
Recruiting
Conditions
Psychiatric Disorders
COVID
Interventions
Diagnostic Test: COVID19 immunization testing
Registration Number
NCT04381845
Lead Sponsor
Assistance Publique - H么pitaux de Paris
Brief Summary

The main objective of this multicenter cohort study is to determine the degree of COVID19 infection immunization of a population of psychiatric patients.

The secondary objective of this cohort follow-up is to:

1. Clinically characterize COVID patients who are positive for serological testing

2. Assess the socio-demographic, clinical and psychotropic determinants of a COVID diagnosis

3. Immunologically characterize COVID patients who are positive for serological testing

4. Exploring the links between susceptibility to COVID19 and erythrocytic blood groups

Detailed Description

All patients accepting to participate will be included in participating psychiatry services and will have a COVID Serological Test for Inclusion with confirmation at J15 including immune-genetics data.

A Comparison of COVID patients versus no COVID patients will be based on a clinical examination (psychiatric, somatic) and blood samples collected at J0 and J15.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Adult patient
  • Hospitalized in one of the participating psychiatric wards during the inclusion period
  • Signed informed consent
Exclusion Criteria
  • Inability to obtain the consent of the patient or legal representative, if applicable
  • Patient under safeguard of justice

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
psychiatric patientCOVID19 immunization testingpatients who are hospitalized in psychiatric department
Primary Outcome Measures
NameTimeMethod
Number of COVID-positive patientsday 15

Number of COVID-positive patients, defined by a positive serological test result by immuno-chromatography at inclusion or at 15 days.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Assistance Publique - H么pitaux de Paris

馃嚝馃嚪

Paris, Ile De France, France

漏 Copyright 2025. All Rights Reserved by MedPath